Is Hengrui a private enterprise or a state-owned enterprise?

Hengrui is a private enterprise. According to the official website National Enterprise Credit Information Publicity System, it is known that Hengrui Pharma was listed on the main board of Shanghai on June 65438+1October 65438+1October 8, 2000, and the opening price on the first day was 26.88 yuan, which rose to1/KLOC-0 at the beginning of October. Hengrui is a private enterprise. Hengrui's management is centralized, which is the management mode of traditional private enterprises. Hengrui is a company that is transforming from generic drugs to innovative drugs. Hengrui insists on using its own laboratory for research, its own team for transformation, its own team for development and its own team for sales. Hengrui adopted the model of "low basic salary+high commission", and achieved the first domestic market share of Docetaxel, Oxaliplatin and Irinotecan in more than five years. In 20021year, the sales volume of Karezumab was about 4 1 100 million yuan, which still ranked first in domestic PD 1.